Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $3.1 million.

  • Editas Medicine's Prepaid Assets fell 4745.99% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4745.99%. This contributed to the annual value of $3.1 million for FY2024, which is 5835.88% down from last year.
  • Latest data reveals that Editas Medicine reported Prepaid Assets of $3.1 million as of Q3 2025, which was down 4745.99% from $3.7 million recorded in Q2 2025.
  • Over the past 5 years, Editas Medicine's Prepaid Assets peaked at $9.5 million during Q3 2021, and registered a low of $3.1 million during Q3 2025.
  • Moreover, its 5-year median value for Prepaid Assets was $6.7 million (2023), whereas its average is $6.3 million.
  • As far as peak fluctuations go, Editas Medicine's Prepaid Assets skyrocketed by 5819.63% in 2024, and later crashed by 6313.6% in 2025.
  • Over the past 5 years, Editas Medicine's Prepaid Assets (Quarter) stood at $7.2 million in 2021, then increased by 1.9% to $7.3 million in 2022, then increased by 2.67% to $7.5 million in 2023, then plummeted by 58.36% to $3.1 million in 2024, then decreased by 0.73% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $3.7 million for Q2 2025, and $3.4 million during Q1 2025.